Arbovirus infection
diseaseOn this page
Also known as Arboviral diseaseARBOVIRUS INFECTArbovirus InfectionsArthropod-borne viral infectionInfection, ArbovirusInfections, Arbovirus
Summary
Arbovirus infection (MONDO:0020731) is a disease and 16 clinical trials. Top therapeutic interventions include baricitinib. A subtype of viral infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 16
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | arbovirus infection |
| Mondo ID | MONDO:0020731 |
| EFO | EFO:1001269 |
| MeSH | D001102 |
| NCIT | C34396 |
| SNOMED CT | 40610006 |
| UMLS | C0003723 |
| MedGen | 389 |
| Is cancer (heuristic) | no |
Also known as: Arboviral disease · ARBOVIRUS INFECT · arbovirus infection · Arbovirus Infections · Arthropod-borne viral infection · arthropod-borne viral infection · Infection, Arbovirus · Infections, Arbovirus
Disease family
This is a subtype of viral infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › viral infectious disease › arbovirus infection
Related subtypes (40): Whitewater Arroyo hemorrhagic fever, exanthema subitum, Zika virus congenital syndrome, common wart, viral labyrinthitis, viral gastritis, vaccinia, viral esophagitis, Kaposi’s sarcoma, contagious pustular dermatitis, epidemic pleurodynia, herpangina, human T-lymphotropic virus 1 infectious disease, lumpy skin disease, milker’s nodule, molluscum contagiosum, Newcastle disease, pharyngoconjunctival fever, pseudorabies, Reoviridae infectious disease, immunodeficiency 32B, focal epithelial hyperplasia, neurolymphomatosis, viral myositis, virus-associated trichodysplasia spinulosa, infective dermatitis associated with HTLV-1, congenital varicella syndrome, viral hemorrhagic fever, arbovirus fever, human infection by orthopoxvirus, congenital Epstein-Barr virus infection, rabies, viral eye infection, viral infection of central nervous system, viral respiratory tract infection, Parvoviridae infectious disease, COVID-19–associated multisystem inflammatory syndrome in children, primary viral infectious disease, disease arising from reactivation of latent virus, human betaherpesvirus 5 infectious disease
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 16.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 14 |
| PHASE3 | 1 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT07543458 | PHASE3 | NOT_YET_RECRUITING | Therapeutics for Moderate and Severe Dengue |
| NCT00116766 | PHASE2 | COMPLETED | Field Evaluation of Plant-based Mosquito Control |
| NCT04615364 | Not specified | RECRUITING | Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia |
| NCT04619823 | Not specified | RECRUITING | Virological and Immunological Determinants of Arbovirus Infection in New Caledonia |
| NCT06599970 | Not specified | ACTIVE_NOT_RECRUITING | Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility |
| NCT06651372 | Not specified | ACTIVE_NOT_RECRUITING | The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return Travelers |
| NCT07229677 | Not specified | RECRUITING | Cohort Study of Arbovirus and Other Emerging Virus Infections in Fiji: AEVI-Fiji Cohort. |
| NCT07291206 | Not specified | RECRUITING | ARBOspot: Characterization of Arbovirus Specific T Cell Response in Patients by Using Enzyme Linked Immunospot (ELISpot) Assays |
| NCT07412977 | Not specified | NOT_YET_RECRUITING | Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort |
| NCT01868399 | Not specified | COMPLETED | Pilot Survey of Dengue Fever in Solomon Islands |
| NCT03210363 | Not specified | COMPLETED | Sero-epidemiology of Priority Arboviruses in French Guiana |
| NCT03552094 | Not specified | UNKNOWN | World Mosquito Program Noumea - Human Sample Component |
| NCT03553277 | Not specified | COMPLETED | Spatial Repellents for Arbovirus Control |
| NCT04954352 | Not specified | UNKNOWN | Human Epidemiology of Newly Identified Arboviruses |
| NCT05452447 | Not specified | COMPLETED | Spatial Repellents for Aedes-borne Virus Control in Sri Lanka |
| NCT06268691 | Not specified | COMPLETED | Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| BARICITINIB | 4 | 1 |
| CHEMBL5427854 | 0 | 1 |
| CHEMBL5435500 | 0 | 1 |
Related Atlas pages
- Drugs: Baricitinib